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Abstract
Background: Genotoxic stress, such as by exposure to bromodeoxyuridine (BrdU) and cigarette smoke, induces
premature cell senescence. Recent evidence indicates that cellular senescence of various types of cells is
accelerated in COPD patients. However, whether the senescence of airway epithelial cells contributes to the
development of airway diseases is unknown. The present study was designed to test the hypothesis that
premature senescence of airway epithelial cells (Clara cells) impairs repair processes and exacerbates inflammation
after airway injury.
Methods: C57/BL6J mice were injected with the Clara-cell-specific toxicant naphthalene (NA) on days 0, 7, and 14,
and each NA injection was followed by a daily dose of BrdU on each of the following 3 days, during which
regenerating cells were allowed to incorporate BrdU into their DNA and to senesce. The p38 MAPK inhibitor
SB202190 was injected 30 minutes before each BrdU dose. Mice were sacrificed at different times until day 28 and
lungs of mice were obtained to investigate whether Clara cell senescence impairs airway epithelial regeneration
and exacerbates airway inflammation. NCI-H441 cells were induced to senesce by exposure to BrdU or the
telomerase inhibitor MST-312. Human lung tissue samples were obtained from COPD patients, asymptomatic
smokers, and nonsmokers to investigate whether Clara cell senescence is accelerated in the airways of COPD
patients, and if so, whether it is accompanied by p38 MAPK activation.
Results: BrdU did not alter the intensity of the airway epithelial injury or inflammation after a single NA exposure.
However, after repeated NA exposure, BrdU induced epithelial cell (Clara cell) senescence, as demonstrated by a
DNA damage response, p21 overexpression, increased senescence-associated b-galactosidase activity, and growth
arrest, which resulted in impaired epithelial regeneration. The epithelial senescence was accompanied by p38
MAPK-dependent airway inflammation. Senescent NCI-H441 cells impaired epithelial wound repair and secreted
increased amounts of pro-inflammatory cytokines in a p38 MAPK-dependent manner. Clara cell senescence in
COPD patients was accelerated and accompanied by p38 MAPK activation.
Conclusions: Senescence of airway epithelial cells impairs repair processes and exacerbates p38 MAPK-dependent
inflammation after airway injury, and it may contribute to the pathogenesis of COPD.
Background
Aging is a risk factor for chronic obstructive pulmonary
disease (COPD) [1]. Recent evidence indicates that cel-
lular senescence of various types of cells is accelerated
in COPD patients, including alveolar type II cells,
endothelial cells, fibroblasts, and peripheral blood lym-
phocytes [2-5]. Cellular senescence is a state of essen-
tially irreversible growth arrest that occurs either as a
result of a large number of cell divisions (replicative
senescence) or exposure to any of wide range of stimuli,
including oncogene activation, oxidative stress, and
DNA damage (premature senescence) [6,7]. Unlike
apoptotic cells, senescent cells remain metabolically
active and are capable of altering their microenviron-
ment for as long as they persist [6,7]. Since senescent
cells accumulate in vivo, they are presumed to contri-
bute to the pathogenesis of age-related diseases, such as
COPD and atherosclerosis, in at least two distinct ways,
first inhibiting tissue repair, because they remain viable
but are unable to divide and to repair tissue defects, and
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second, by acting as a source of chronic inflammation,
because senescent cells have been shown to secrete pro-
inflammatory mediators [1,6-10]. However, whether the
senescence of airway epithelial cells contributes to the
development of airway diseases is unknown.
Clara cells are the principal progenitors of the distal
airway epithelium [11-14]. Clara cells of mice and cer-
tain other species are rich in a cytochrome P450 enzyme
(CYP2F2) and therefore are sensitive to the toxic effects
of naphthalene (NA), which is metabolized to a toxic
intermediate by the enzyme [11-14]. Repair of the air-
way epithelium after NA injury is accomplished in sev-
eral overlapping stages. In mice, the proliferative
response peaks 1 to 2 days after NA injury and is fol-
lowed by the differentiation phase, which is normally
completed in 2 weeks [13].
We hypothesized that senescence of airway epithelial
cells impairs repair processes and exacerbates inflamma-
tion after an airway injury. To test this hypothesis, we
utilized a well-established murine model of NA-induced
Clara cell depletion. To induce airway epithelial cell
senescence in this model, we intraperitoneally injected
mice with the brominated thymidine analog 5-bromo-2’-
deoxyuridine (BrdU) after NA injury. BrdU is incorpo-
rated into DNA during the S-phase of the cell cycle, and
is commonly used to identify and track proliferating
cells. However, emerging evidence indicates that BrdU
imposes genotoxic stress that induces premature senes-
cence and therefore limits cell’s proliferative response to
growth stimuli [15-18]. In this study we demonstrated
that administration of BrdU following repeated exposure
to NA induced epithelial cell (Clara cell) senescence and
p38 mitogen-activated protein kinase (MAPK)-depen-
dent inflammation in the distal airway epithelium of
mice. These findings suggest that airway epithelial cell
senescence impairs repair processes and exacerbates
inflammation after airway injury, and presumably contri-
butes to pathological alterations in the airways of COPD
patients.
Methods
Animal protocol
The animal protocol was reviewed and approved by the
Animal Care, Use, and Ethics Committee of Tokyo
Women’s Medical University. Eight-week-old male C57/
BL6J mice were intraperitoneally injected with NA
(Kanto Chemical, Tokyo, Japan: 200 mg/kg body wt) or
corn oil vehicle on day 0 alone (acute model), or on
days 0, 7, and 14 (chronic model). Each NA injection
was followed by intraperitoneal injection of BrdU
(Sigma, St. Louis, MO: 200 mg/kg body wt) or 0.3% car-
boxymethycellulose, on 3 consecutive days (days 1-3, 8-
10, and 15-17). This BrdU administration schedule was
chosen because epithelial proliferation in mice is
maximal 1 to 2 days after exposure to NA [13]. The p38
mitogen-activated protein kinase (MAPK) inhibitor
SB202190 (Enzo Life Sciences, Plymouth Meeting, PA)
or 0.1% DMSO was administered by intraperitoneal
injection 30 minutes before each BrdU injection. Ani-
mals were killed on days 1, 2, 3, 4, 11, or 28 by injecting
an overdose of pentobarbital sodium [19].
Human lung tissue samples
The protocol of the study conformed to the Declaration
of Helsinki, and approval from the Tokyo Women’s
Medical University Institutional Review Board was
obtained. Lung tissue blocks were obtained from COPD
patients (n = 14), asymptomatic smokers (n = 7), and
asymptomatic nonsmokers (n = 8) during lung volume
reduction surgery or pulmonary resection for localized
lung cancer. The clinical information regarding these
patients is shown in Table 1.
Tissue preparation
Lungs of mice were inflation fixed in situ for 5 minutes
with 10% neutral buffered formalin (NBF) at 25 cm
water pressure, removed, and immersion fixed in NBF
for 24 hours. Formalin-fixed tissue was embedded in
paraffin, and sectioned (3 μm). For frozen fixation, lungs
were inflated by manual instillation of 50% optimal cut-
ting temperature compound, quickly frozen, and sec-
tioned (3 μm). The tissue blocks from human lungs
were fixed in NBF, embedded in paraffin, and sectioned
(3 μm).
Cell culture
NCI-H441 cells (the American Type Culture Collection,
Rockville, MD), a Clara-cell-like human lung adenocar-
cinoma cell line, were cultured in RPMI 1640 supple-
mented with 10% FCS. Cells were exposed to BrdU by
culturing for 10 days in the presence of BrdU (25, 50, or
100 μM), with a medium exchange on day 5; control
cells were similarly cultured in the absence of BrdU. In
some experiments, the p38 MAPK inhibitor SB202190
was added to a concentration 10 μM [19]. For
Table 1 Characteristics of the subjects
COPD patients Smokers Nonsmokers
(n = 14) (n = 7) (n = 8)
Male/females, n 12/2 7/0 2/6
Age, years 65.9 ± 2.2 60.9 ± 6.3 64.3 ± 3.8
Smoking, pack years 80.0 ± 14.1†† 50.7 ± 6.2† 0 ± 0
FEV1, liters 0.91 ± 0.11** 2.35 ± 0.17 2.14 ± 0.12
FEV1/FVC, % 34.0 ± 3.4** 75.4 ± 2.9 75.0 ± 4.3
FEV1, % predicted 35.5 ± 4.0** 91.0 ± 6.4 101.2 ± 5.4
The COPD patients and smokers were ex-smokers. **P < 0.01 compared to
asymptomatic smokers and nonsmokers. †P < 0.05 and ††P < 0.01 compared
to asymptomatic nonsmokers.
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telomerase inhibition, cells were cultured for 28 days in
the presence of MST-312 (2.5 μM: Calbiochem, Gibbs-
town, NJ), with passages every 7 days; control cells were
similarly cultured in the absence of MST-312 [20]. Cell
numbers were counted manually or by Alamar®blue
assay (Invitrogen, Camarillo, CA). Population doubling
(PD) at each passage was calculated by using the for-
mula: PD = ln (number of cells recovered/number of
cells inoculated)/ln2.
Epithelial repair assay
NCI-H441 cells were cultured on 30 mm-plates in
RPMI 1640 supplemented with 10% FCS in the presence
or absence of 25 μM BrdU for 10 days. Cell monolayers
were then damaged mechanically by crossing three
times with a 10-200 μl volume universal pipette tip
(Corning, NY, USA) and epithelial repair after mechani-
cal damage was monitored for 72 hours. (See Additional
file 1 for details.)
Enzyme-linked immunosorbent assay (ELISA)
The concentrations of cytokines/chemokines in the cell
culture supernatants were measured by using ELISA kits
(Biosource International, Camarillo, CA), and values
were normalized to the number of cells.
Senescence-associated b-galactosidase (SA b-gal) staining
SA b-gal staining was performed as described previously
[21]. (See Additional file 1 for details.)
Immunohistochemistry and immunofluorescence
The primary antibodies against Clara cell 10-kDa secre-
tory protein (CC10), b-tubulin IV, Ki-67, BrdU, p16INK4a
(p16), p21WAF1/CIP1 (p21), phospho(Thr180/Tyr182)-p38
MAPK, polyclonal anti-phospho(Ser/Thr)-ataxia telean-
giectasia mutated kinase (ATM)/ataxia teleangiectasia
and Rad3-related kinase (ATR) substrate, phospho
(Ser139)-H2AX (gH2AX), CD45, and CD90.2 were used.
For immunohistochemistry and immunocytochemistry,
the primary antibodies were detected with a secondary
antibody conjugated with a horseradish-peroxidase
(HRP)-labeled polymer (Envison+®, DAKO Japan,
Tokyo, Japan; Histofine® Simple Stain, Nichirei Bios-
ciences, Tokyo Japan). Immunoreactants were detected
with a diaminobenzidine substrate or a HistoGreen®
substrate (AbCys, Paris, France). (See Additional file 1
for details.) For immunofluorescence staining, the pri-
mary antibodies were reacted with secondary anti-IgG
antibodies conjugated with Alexa Fluor 350, Alexa Fluor
488, or Alexa Fluor 594 (Invitrogen, Carlsbad, CA).
Images were acquired by using an Olympus BX60
microscope (Olympus Optical Co., Ltd., Tokyo, Japan)
equipped with a digital camera, and processed with a
computerized color image analysis software system (Win
Roof Version 3.5; Mitani Corporation, Fukui, Japan) and
Adobe Photoshop software (San Jose, CA). The numbers
of gH2AX-foci in the cell nuclei of at least 50 cells were
counted visually through an Olympus BX60 microscope
equipped with a 100× objective as described previously
[22,23].
Immunoblot analysis
Cell lysates were fractionated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred to a
polyvinylidene difluoride membrane. The membrane
was probed with primary antibodies against phospho
(Thr180/Tyr182)-p38 MAPK, p38 MAPK, NF-B p65,
phospho-NF-B p65 (Ser536), phospho(Ser139)-H2AX
(gH2AX, Cell Signaling), p21, or actin (See Additional
file 1 for details.)
Cell cycle analysis
The DNA content of cells was analyzed by flow cytome-
try [24].
Morphometric analysis in murine distal airways
Morphometric analysis was performed in the distal
bronchiolar airway region. Since cell type representation
varies with anatomical location, the analysis was limited
to the final 200-μm basement membrane (BM) that
ended in a well-defined bronchoalveolar duct junction
[25]. The distal bronchiolar airway epithelium was
defined as the cells located between the basal lamina
and the airway lumen, and the peribronchiolar intersti-
tium was defined as the cells located between the basal
lamina of the distal bronchiolar airway epithelium and
an adjacent blood vessel, alveolus, or bronchiole. Ten
distal bronchiolar airways were randomly selected on
each slide and examined under a microscope at ×400
magnification.
Epithelial injury was quantified on hematoxylin-eosin-
stained slides by counting the number of necrotic bron-
chial epithelial cells that had exfoliated into the airway
lumen and dividing the number by the total length of
the BM. Clara cells were identified by immunohisto-
chemistry for CC10, and the number of CC10-positive
cells in the epithelium was divided by the total length of
the BM. Epithelial cell proliferation was quantified by
dividing the number of Ki-67-labeled nuclei in the
CC10-positive cells by the total number of CC10-posi-
tive cells, or the number of Ki-67-labeled nuclei in the
CC10-negative epithelial cells by the total number of
CC10-negative epithelial cells. Epithelial cell senescence
was quantified by counting the number of p21-labeled
nuclei in CC10-positive cells or the number of SA b-
gal-positive cells that co-express CC10 and dividing the
number by the total number of CC10-positive cells.
DNA damage response was quantified by dividing the
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number of phospho-ATM/ATR substrate-labeled nuclei
in the CC10-positive cells by the total number of CC10-
positive cells, or by counting the number of gH2AX foci
in CC10-positive cells. Activation of p38 MAPK was
quantified by dividing the number of phospho-p38
MAPK-labeled nuclei in the CC10-positive cells by the
total number of CC10-positive cells. Airway inflamma-
tion was evaluated by counting the number of CD45-
positive cells (pan-leukocytes) and the number of
CD90.2-positive cells (T-cells) in the peribronchiolar
interstitium and dividing their numbers by the total
length of the BM.
Morphometric analysis of human bronchiolar airways
Human lung tissue sections were triple immunofluores-
cence stained for CC10, p16, and phospho-p38 MAPK,
and five microscopic fields of tissue from each patient
containing a region of distal bronchiolar airway epithe-
lium were examined under an epifluorescence micro-
scope at ×400 magnification. The number of CC10-
positive cells that stained positive for p16 was divided
by the total number of CC10-positive cells, the number
of CC10-positive cells that stained positive for phospho-
p38 MAPK was divided by the total number of CC10-
positive cells, and the number of CC10-positive cells
that stained positive for both phospho-p38 MAPK and
p16 was divided by the total number of CC10-positive
cells. The number of CC10-positive cells that stained
positive for both phospho-p38 MAPK and p16 was
divided by the total number of CC10-positive cells that
stained positive for p16 (p38 MAPK index for senescent
Clara cells), and the number of CC10-positive cells that
were positive for phospho-p38 MAPK but negative for
p16 was divided by the total number of CC10-positive
cells that were negative for p16 (p38 MAPK index for
presenescent Clara cells).
Statistical analysis
Data are expressed as means ± SEM. Statistical analyses
were performed by using the Excel X software program
with the add-in software Statcel 2 (OMS, Tokyo, Japan).
Data obtained from two groups were compared by using
Student’s t-test. Comparisons among three or more
groups were made by analysis of variance (ANOVA),
and any significant differences were further examined by
the Tukey-Kramer comparisons post hoc test. Data were
tested for correlations by the Spearman rank correlation
test. A p value of < 0.05 was considered significant.
Results
BrdU does not affect acute epithelial damage, repair, or
inflammation after a single exposure to NA
We first investigated whether administration of BrdU
would exacerbate airway epithelial damage after a single
exposure to NA. Previous studies have shown that a sin-
gle exposure to NA induces acute, selective injury of the
Clara cells of the distal airway epithelium within 2 days.
Acute NA injury is followed by epithelial cell prolifera-
tion and re-differentiation and normally resolves in two
weeks [12-14]. As shown in Figure 1A, on day 1 after
NA exposure the Clara cells of the distal airway epithe-
lium were vacuolated and swollen, and many of the cells
exfoliated into the airway lumen. Ciliated cells had
become squamous and extended to cover the denuded
BM. Administration of BrdU on days 1, 2, and 3 post-
NA exposure did not affect the intensity of the epithelial
cell exfoliation into the airway lumen (Figure 1B) or
reduction and subsequent recovery in the number of
Clara cell 10-kDa secretory protein (CC10)-positive cells
(Clara cells) remaining within the airway epithelium
(Figure 1C). No histological changes were observed in
the lungs of mice exposed to BrdU alone.
NA-induced epithelial damage was followed by airway
infiltration by neutrophils and mononuclear lympho-
cytes. BrdU did not alter the intensity of CD45-positive
cell (pan-leukocytes) infiltration of the distal airways of
mice exposed to NA (Figure 1D). Thus, BrdU did not
affect the “acute” airway epithelial damage, repair, or
inflammatory response after a single NA exposure.
BrdU impairs epithelial regeneration after repeated NA
exposure
The above findings indicated that BrdU does not aggra-
vate NA-induced airway epithelial damage. However,
previous studies showed that long-term exposure to
BrdU imposes genotoxic stress that induces premature
senescence and limits the proliferative response of cells
to growth stimuli [15-18]. We therefore investigated
whether BrdU administration to mice would eventually
induce senescent growth arrest that impaired the epithe-
lial regenerative response to repeated airway injury. To
do so, mice were injected with NA once a week for 3
weeks (days 0, 7, and 14), and each NA injection was
followed by administration of BrdU on 3 consecutive
days (days 1-3, 8-10, and 15-17), during which regener-
ating cells were allowed to incorporate BrdU into their
DNA and to senesce. The mice were sacrificed on day
28, which allowed the airway epithelium to recover for
14 days after the final exposure to NA.
The distal airway epithelium of the mice exposed to
NA on days 0, 7, and 14 and sacrificed on day 28 was
mostly composed of CC10-positive Clara cells, but occa-
sional b-tubulin-positive ciliated cells and CC10-nega-
tive, b-tubulin-negative nondescript cells were observed
(Figure 2A). The number of CC10-positive cells in the
distal airway epithelium of the mice was 69% of the
basal level, indicating that regeneration was still conti-
nuing when the mice were sacrificed (Figure 2C).
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Figure 1 BrdU does not affect the intensity of acute airway epithelial damage, recovery, or inflammation after a single exposure to
NA. Mice were intraperitoneally injected with NA or corn oil vehicle (day 0) and then intraperitoneally injected with BrdU or 0.3%
carboxymethycellulose on days 1, 2, and 3. Animals were killed on days 1, 2, 3, 4, and 11. On days 1, 2, and 3 the mice were killed before the
BrdU injection. (A) Hematoxylin-eosin stained (upper panels) and anti-CC10 immunostained (lower panels) lung tissue of mice on day 1 after
exposure to NA or control vehicle. The lungs of the mice exposed to NA contain many distal airway epithelial cells (Clara cells) that are
vacuolated, swollen, and have exfoliated into the airway lumen. (B-D) Time course of epithelial cell damage and airway inflammation after a
single exposure to NA. Open circles: mice injected with NA alone. Closed circles: mice injected with both NA and BrdU. BrdU had not affected the
degree of NA-induced epithelial cell damage, recovery (B and C), or airway inflammation (D) at any of the time points evaluated. Data are
expressed as the means ± SEM. N = 4-5 at each time point for each group of mice. BM: basement membrane. No histological changes were
observed in the lungs of mice injected with BrdU alone (photographs not shown).
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However, in the mice exposed to NA (days 0, 7, and 14)
and injected with BrdU (days 1-3, 8-10, and 15-17), the
number of CC10-positive cells in the distal airway
epithelium had recovered to only 55% of the basal level,
indicating that regeneration was impaired.
Different cell types participate in the regenerative
response to NA-induced Clara cell depletion in the dis-
tal airway, and they include surviving CC10-positive
Clara cells and a subpopulation of CC10-positive epithe-
lial cells that consists of a pollutant-resistant subpopula-
tion of Clara cells that retain expression of CC10
(variant CC10/CCSP-expressing cells; vCE cells),
bronchoalveolar stem cells (BASCs), and CC10-negative
cells, such as pulmonary neuroendocrine cells (PNECs)
and ciliated cells [26]. The mice that had received NA
and BrdU had lower percentages of both CC10-positive
Figure 2 BrdU impairs epithelial regeneration after repeated NA exposure in mice. Mice were injected with NA once a week for 3 weeks
(days 0, 7, and 14), and each NA injection was followed by administration of BrdU on 3 consecutive days. The animals were sacrificed on day
28, and lung tissue sections were double immunostained for (A) CC10 (green) and b-tubulin (brown), (B) CC10 (green) and Ki-67 (brown), and (E)
BrdU (green) and Ki-67 (brown). Arrowheads indicate CC10-positive cells that express Ki-67. Arrows indicate cells that stained positive for BrdU.
Broken arrows indicate cells that express Ki-67. (C and D) Quantitative analyses of the number of CC10-positive cells within the distal airway
epithelium (C), and the proportion of CC10-positive cells that express Ki-67 and the proportion of CC10-negative cells that express Ki-67 (D). Data
are expressed as the means ± SEM. N = 4-6 in each group of mice. BM: basement membrane. Panel E shows that very few BrdU-positive cells
(green) stained positive for Ki-67 (brown).
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epithelial cells that expressed Ki-67 and CC10-negative
epithelial cells that expressed Ki-67 than the mice that
received NA alone (Figure 2B and 2D). These results
suggest that BrdU blunted the proliferative response of
airway epithelial progenitor cells (whether CC10-positive
or CC10-negative). Furthermore, 34.9% of the CC10-
positive cells and 7.5% of the CC10-negative cells in the
distal airway epithelium of the mice that had received
both NA and BrdU stained positive for BrdU, indicating
that they had divided by day 17 (the final day of BrdU
administration) and incorporated BrdU into their DNA
during the S-phase of the cell cycle. However, very few
(< 0.1%) of the BrdU-positive cells were positive for Ki-
67 (Figure 2E). Thus, the epithelial cells that had incor-
porated BrdU became unable to proliferate.
BrdU induces epithelial cell senescence after repeated NA
exposure
Next, we investigated whether the impaired regeneration
of the airway epithelium in the mice repeatedly exposed
to NA and BrdU was attributable to induction of cellu-
lar senescence. Senescence of airway epithelial cells was
detected by histological staining of lung tissue samples
obtained on day 28 for different senescence markers,
including phospho-ATM/ATR substrates and phospho-
H2AX (gH2AX) (markers for DNA damage response),
p21 (a marker for senescence growth arrest), and SA b-
gal (reviewed in reference 7). gH2AX, a variant form of
the H2A protein, is a component of the histone octomer
in nucleosomes and phosphorylated by the kinase ATM/
ATR in the phosphoinositide 3-kinase (PI3K) pathway as
the first step in recruiting and localizing DNA repair
proteins [22,27]. Some CC10-positive cells in the distal
airway epithelium of the mice repeatedly exposed to NA
stained positive for phospho-ATM/ATR, gH2AX, p21,
and SA b-gal (Figure 3A), whereas 1.5 to 2 times more
CC10-positive cells in the mice that had received both
NA and BrdU stained positive for these senescence mar-
kers (Figure 3A and 3B). When SA b-gal-stained lung
tissue samples were immunostained for BrdU, many of
the SA b-gal-positive cells stained positive for BrdU
(Figure 3C), suggesting that the BrdU incorporation pre-
ceded the senescence of epithelial cells. Collectively,
these results suggest that BrdU induced senescence of
the CC10-positive cells (i.e., Clara cells) in the airways
of mice that had been exposed to NA.
Epithelial cell senescence is accompanied by severer
airway inflammation
Since the repair process after NA injury is accompanied
by airway inflammation, we next evaluated the severity
of airway inflammation in the mice that had received
NA alone or both NA and BrdU. The distal airways of
the mice that had repeatedly received both NA and
BrdU contained greater numbers of CD45-positive cells
(pan-leukocytes) and CD90.2-positive cells (T-cells) than
the distal airways of the mice that had received NA
alone (Figure 4). Thus, the induction of epithelial cell
senescence by BrdU was accompanied by exacerbation
of airway inflammation.
BrdU induces cellular senescence, impairs wound repair,
and pro-inflammatory cytokine secretion by NCI-H441
cells
Next, we established a link that connected cellular
senescence and inflammation in cultures of NCI-H441
cells, a human lung adenocarcinoma cell line with Clara
cell characteristics. Trypan blue staining showed that no
cell deaths occurred when NCI-H441 cells were exposed
to BrdU at concentrations of 100 μM or less (data not
shown). However, when the cells were exposed to BrdU
at 25, 50, and 100 μM for 10 days, they dose-depen-
dently displayed senescence phenotypes, as exemplified
by increased SA b-gal activity (Figure 5A), a distinct,
flat, and enlarged morphology (Figure 5A), growth arrest
(Figure 5B), and p21 expression (Figure 5C). When
NCI-H441 cells were exposed to BrdU at any of these
three concentrations for 10 days, washed in PBS, and
then stimulated with 10% FCS for 3 days, cell growth
did not resume, confirming the irreversibility of the
senescence growth arrest (data not shown). In addition,
the cellular senescence induced by BrdU exposure was
accompanied by phosphorylation of H2AX (gH2AX)
(Figure 5D), suggesting that the genotoxic stress
imposed by BrdU contributed to the induction of senes-
cence [15-18]. To investigate whether cell senescence
impairs the self-repair capacity of epithelial cells, mono-
layers of NCI-H441cells cultured in the presence or
absence of 25 μM BrdU were mechanically damaged.
The damaged area in BrdU-exposed monolayers was
repopulated more slowly than that in unexposed mono-
layers (Figure 5E), suggesting that cell senescence
impaired epithelial wound repair.
As shown in Figure 6A, NCI-H441 cells exposed to
BrdU for 10 days secreted 15- to 30-times greater
amounts of the pro-inflammatory cytokines IL-6, TNFa,
and GM-CSF than unexposed cells secreted. However,
the amount of the anti-inflammatory cytokine IL-10
secreted by both the BrdU-exposed cells and unexposed
cells was below the limit of detection (< 3.1 pg/ml), sug-
gesting that a pro-inflammatory shift occurred after
BrdU exposure. Exposure to BrdU for only 24 hours did
not stimulate NCI-H441 cells to secrete pro-inflamma-
tory cytokines (0.33 ± 0.02 fg/cell GM-CSF secreted by
BrdU-exposed cells vs. 0.24 ± 0.07 fg/cell GM-CSF
secreted by control cells, P = 0.38), indicating that the
pro-inflammatory cytokine secretion in response to
BrdU was not due to a direct stimulatory effect on the
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Figure 3 BrdU induces epithelial cell senescence after repeated NA exposure in mice. (A) Lung tissue sections were double stained for
gH2AX (green fluorescence) and CC10 (red fluorescence), for phospho-ATM/ATR substrates (brown) and CC10 (green), for p21 (brown) and CC10
(green), or for SA b-gal (green) and CC10 (brown). White arrows indicate gH2AX foci in the nuclei of CC10-positive cells. Black arrows indicate
CC10-positive cells that express phospho-ATM/ATR substrates, p21, or SA b-gal. (B) Quantitative analyses of the number of gH2AX foci in CC10-
positive cells and the proportion of CC10-positive cells that express phospho-ATM/ATR substrates, p21, or SA b-gal. Data are expressed as the
means ± SEM. N = 4-6 in each group of mice. Panel C shows epithelial cells that are double positive for SA b-gal (green) and BrdU (brown)
(broken arrows)
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cells. To determine whether senescence inducers other
than BrdU also increase pro-inflammatory cytokine
secretion, NCI-H441 cells were cultured for 30 days in
the presence or absence of the telomerase inhibitor
MST-312 [20]. Exposure to MST-312 induced senes-
cence growth arrest and markedly increased secretion of
TNFa, IL-1b, and IL-8 by NCI-H441 cells (Figure 7).
These results suggest that the increase in senescence-
associated pro-inflammatory cytokine secretion was not
an effect that was peculiar to BrdU.
The signaling pathways that lead to pro-inflammatory
cytokine secretion usually involve activation of various
molecules, including NF-B and p38 MAPK. Immuno-
blot analyses showed that exposure of NCI-H441 cells
to BrdU for 10 days significantly increased phosphoryla-
tion of p38 MAPK but not of NF-B (Figure 6B).
Furthermore, treatment of NCI-H441 cells with the p38
MAPK inhibitor SB202190 substantially reduced the
increases in levels of IL-6, TNFa, and GM-CSF secreted
by BrdU-exposed cells (Figure 6A). By contrast,
SB202190 did not inhibit the BrdU-induced growth
arrest or SA b-gal activation (Figure 6C). These results
suggest that p38 MAPK activation is required for the
senescence-associated pro-inflammatory cytokine secre-
tion after induction of NCI-H441 cell senescence by
BrdU but not for the growth arrest.
P38 MAPK inhibitor suppresses senescence-associated
inflammation in murine airways
Next, we investigated whether SB202190 would inhibit
senescence-associated inflammation in murine airways.
The percentage of CC10-positive cells that expressed
phospho-p38 MAPK was higher in the mice repeatedly
exposed to NA and BrdU than in the control mice (Fig-
ure 8A and 8B). Treatment of the mice with SB202190
reduced not only the increase in the proportion of
CC10-positive cells that expressed phospho-p38 MAPK
(Figure 8B) but the increases in numbers of CD45-posi-
tive cells and CD90.2-positive cells that infiltrated the
distal airways (Figure 8C). By contrast, SB202190 did
not inhibit the reduction in the number of CC10-posi-
tive cells or the increase in the percentage of CC10-
positive cells that expressed p21 in the distal airways of
the mice (Figure 8D and 8E). These results suggest that
SB202190 inhibits senescence-associated inflammation
but not senescence growth arrest in the murine model
of BrdU-induced epithelial senescence.
P38 MAPK activation in senescent Clara cells in the
airways of COPD patients
The results obtained in the experiments on mice and cell
cultures suggested that BrdU induces senescence of
epithelial cells (Clara cells and NCI-H441 cells) that is
accompanied not only by impaired epithelial regeneration
but also by p38 MAPK-dependent exacerbation of the
inflammatory response. We therefore investigated
whether Clara cell senescence is accelerated in the air-
ways of COPD patients, and if so, whether it is accompa-
nied by p38 MAPK activation. The distal airway
epithelium of COPD patients was found to contain signif-
icantly higher percentages of CC10-positive cells that
were positive for p16, CC10-positive cells that were posi-
tive for phospho-p38 MAPK, and CC10-positive cells
that were positive for both p16 and phospho-p38 MAPK
than the distal airway epithelium of asymptomatic non-
smokers (Figure 9A and 9B). When all of the subjects
were included in a correlation analysis, the percentage of
p16-positive Clara cells was found to be correlated with
the percentage of phospho-p38 MAPK-positive Clara
cells (Figure 9C). These results suggest that the Clara
Figure 4 Epithelial cell senescence after repeated NA exposure is accompanied by exacerbated airway inflammation. Lung tissue
sections were immunostained for CD45 or CD90.2 and counterstained with hematoxylin. Arrows indicate immunopositive cells (brown). Results of
quantitative analyses of the numbers of CD45-positive cells and CD90.2-positive cells in the distal airways are shown in Figure 8C.
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Figure 5 BrdU induces cellular senescence in Clara-cell-like human lung adenocarcinoma cells. NCI-H441 cells were exposed to BrdU at
sublethal concentrations of 25, 50, or 100 μM for 10 days and evaluated for (A) SA b-gal activity, (B) cell cycle progression by flow cytometry, (C)
p21 expression by immunoblotting and immunofluorescence, and (D) gH2AX expression by immunofluorescence. (E) Epithelial wound repair in
the presence (closed circles) or absence (open circles) of 25 μM BrdU after mechanical damage of NCI-H441 cell monolayers. Data are expressed
as the means ± SEM. N = 3-9 in each experiment. *P < 0.05 vs. cells not exposed to BrdU.
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Figure 6 Senescence of NCI-H441 cells after exposure to BrdU for 10 days is accompanied by p38 MAPK-dependent pro-inflammatory
cytokine production. (A) ELISA to measure concentrations of IL-6, TNF-a, and GM-CSF in the culture supernatants of NCI-H441 cells exposed or
not exposed to 25 μM of BrdU in the presence or absence of 10 μM of the p38 MAPK inhibitor SB202190. The concentration of the anti-
inflammatory cytokine IL-10 was below the limit of detection. (B) Immunoblot analyses for phosphorylation levels of p38 MAPK and NF-B in the
cell lysates. (C) Effects of SB202190 on BrdU-induced SA b-gal activation and growth arrest. Data are expressed as the means ± SEM. N = 3-6 in
each experiment.
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cells in the airways of COPD patients senesce more
rapidly and express higher levels of p38 MAPK activa-
tion. We also found that a higher percentage of CC10-
positive cells that were positive for p16 (i.e., senescent
Clara cells) expressed phospho-p38 MAPK than CC10-
positive cells that were negative for p16 (i.e., presenescent
Clara cells), indicating that MAPK activation is correlated
with senescence at the cellular level in vivo (Figure 9D).
Higher positive phospho-p38 MAPK rates among senes-
cent Clara cells than among presenescent Clara cells
were observed in all of the subjects as a whole and in
each of the subgroups, i.e., the COPD patients, asympto-
matic smokers, and nonsmokers (Figure 9D). These
results suggest greater activation of p38 MAPK in senes-
cent Clara cells than in presenescent cells in both the
presence and absence of COPD.
Discussion
The results of the present study demonstrated that
BrdU-induced senescence of airway epithelial cells
Figure 7 The telomerase inhibitor MST-312 induces cellular senescence and pro-inflammatory cytokine production. NCI-H441 cells were
cultured for 28 days in the presence (closed circles) or absence (open circles) of 2.5 μM MST-312, with passages every 7 days. (A) Population
doubling of NCI-H441 cells exposed and not exposed to the telomerase inhibitor. (B) Concentrations of pro-inflammatory cytokines in the culture
supernatants. Data are expressed as the means ± SEM. *P < 0.05 and **P < 0.01 vs. cells not exposed to BrdU. N = 3-5 in each group.
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Figure 8 P38 MAPK inhibitor suppresses senescence-associated airway inflammation in mice. (A) Representative photomicrographs of
double immunofluorescence staining for phospho-p38 MAPK (green) and CC10 (red) in the distal airway. Arrows indicate CC10-positive Clara cells
that express phospho-p38 MAPK in their nuclei. Treatment with SB202190 of mice repeatedly exposed to NA and injected with BrdU reduces the
proportion of Clara cells that express phospho-p38 MAPK (B) and the numbers of CD45-positive cells and CD90.2-positive cells infiltrating the
distal airways (C) but does not affect the number of Clara cells (D) or the number of Clara cells that express p21 (E). Data are expressed as the
means ± SEM. N = 4-6 in each experiment.
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Figure 9 P38 MAPK activation in senescent Clara cells in the airways of COPD patients. (A) Representative photomicrographs of triple
immunofluorescence staining of lung tissue sections obtained from COPD patients. Arrows indicate CC10-positive Clara cells that express both
p16 and phospho-p38 MAPK. The arrowhead indicates a CC10-positive cell that expresses p16 but not phospho-p38 MAPK (B) Percentages of
CC10-positive Clara cells that express p16, CC10-positive Clara cells that express phospho-p38 MAPK, and CC10-positive Clara cells that express
both p16 and phospho-p38 MAPK in the lungs of COPD patients (C: n = 14), asymptomatic smokers (S: n = 7), and asymptomatic nonsmokers
(NS: n = 8). (C) Correlation between the percentage of CC10-positive Clara cells that express p16 and the percentage of CC10-positive Clara cells
that express phospho-p38 MAPK. Open circles = asymptomatic nonsmokers; open triangles = asymptomatic smokers; closed circles = COPD
patients. (D) Rates of immunopositivity for phospho-p38 MAPK in CC10-positive Clara cells that express p16 (senescent Clara cells) and in CC10-
positive Clara cells that do not express p16 (presenescent Clara cells) in the subjects as a whole, asymptomatic nonsmokers, asymptomatic
smokers, and COPD patients.
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impairs epithelial regeneration and stimulates p38
MAPK-dependent inflammation after NA-induced Clara
cell depletion in mice. To our knowledge, this is the
first evidence indicating that epithelial cell senescence
contributes to incomplete repair and excessive inflam-
mation in the airways of mice. The results of the study
also showed for the first time that Clara cell senescence
is accelerated in COPD patients and is accompanied by
p38 MAPK activation, suggesting that epithelial cell
senescence may contribute to the excessive inflamma-
tion in the airways of COPD patients.
We used BrdU as an inducer of premature senescence to
model airway epithelial senescence in mice and using
BrdU offered several advantages in the present study. First,
induction of senescence by exposure to BrdU has well
been established as a model of premature senescence in
various types of cells [16-19]. Second, since NA selectively
injures Clara cells, using NA in combination with BrdU
facilitated selective induction of senescence of the airway
epithelial cells, and allowed only proliferative epithelial
cells to incorporate BrdU into their DNA during the cell
division that commenced to restore the NA-depleted pool
of Clara cells. This is supported by our findings that while
BrdU induced senescence in an in vitro culture of prolifer-
ating NCI-H441 cells, BrdU itself did not induce senes-
cence of quiescent airway epithelial cells in mice that had
not been exposed to NA. We therefore think that the
senescent CC10-positive cells found in the mice exposed
to NA and BrdU were mostly derived from Clara cells,
which are the major progenitors of cells in the distal air-
ways, but may have included a subpopulation of Clara
cells, such as vCE cells or BASCs, that function as progeni-
tors capable of renewing NA-injured airway epithelium
[26]. Third, immunostaining for Ki-67 (proliferation mar-
ker) and SA b-gal (senescence marker) in combination
with BrdU immunostaining made it possible to track the
fate of the epithelial cells that had incorporated BrdU into
their DNA. In fact, we found that the epithelial cells that
had incorporated BrdU into their DNA became senescent
and no longer proliferated. However, a limitation of our
study stems from the fact that the BrdU taken up by the
cells is phosphorylated to deoxynucleotide monopho-
sphate by the salvage pathway enzyme thymidine kinase,
whose levels may differ from cell to cell [28], and thus the
repeated BrdU injection of mice may have selected for a
subset of cells that had a lower level of the salvage enzyme
and were no longer able to incorporate BrdU into their
DNA. Such selection may have biased the results of our
study. Another limitation of our study is the fact that we
used BrdU, not cigarette smoke, to induce cell senescence,
which may make it uncertain to translate the results of
animal experiments to human COPD.
However, our murine model of Clara cell senescence
provided clear evidence that senescence impairs
regenerative response to airway injury. This finding is not
surprising because senescent cells no longer proliferate in
response to growth stimulation [6,7]. The impaired regen-
erative response in the present study was not due to a
direct cytotoxic effect of BrdU, because BrdU did not
cause any discernible epithelial damage, and it did not
exacerbate the NA-induced epithelial damage in the air-
way of the mice (Figure 1). By contrast, BrdU imposed
genotoxic stress, as demonstrated by the phosphorylation
of ATM/ATR substrates and gH2AX (Figure 3), which
triggers the DNA damage signaling pathway that causes
p21-dependent cell cycle arrest, and eventually an irrever-
sible senescence arrest [6,7,29].
Recent evidence suggests that airway epithelial cells,
including Clara cells, play a pro-inflammatory role in the
immune response through secretion of pro-inflammatory
cytokines [30,31]. In the present study we found that
Clara cell senescence was accompanied by exacerbation
of airway inflammation that was at least in part attributa-
ble to increased pro-inflammatory cytokine secretion by
senescent epithelial cells (Clara cells). These findings cor-
roborate those of previous studies showing that other
senescence inducers, including oncogene activation,
DNA damage, and telomere shortening, stimulate pro-
inflammatory cytokine secretion by cultured fibroblasts
and endothelial cells, a phenomenon termed the “senes-
cence-associated secretory phenotype (SASP)” [10,32-38].
Our study also showed that senescent-associated inflam-
mation occurs in vitro as well as in vivo, and identified
p38 MAPK activation as a positive regulator of the senes-
cence-associated inflammation. P38 MAPK activation is a
crucial step in the synthesis of several pro-inflammatory
cytokines and recent evidence indicates a critical role of
the p38 MAPK pathway in proinflammatory cytokine
production by cells that have undergone oncogene- and
environmental stress-induced senescence [39,40]. Similar
to the findings in our own study, a previous study
showed that inhibition of p38 MAPK by SB202190
reduced expression of IL-8 by fibroblasts after oncogene-
induced senescence [33]. Other potential regulators of
senescence-associated inflammation include the tran-
scription factors NF-B and C/EBPb [10,41]. Although
no significant NF-B activation in the BrdU-induced
senescent NCI-H441 cells was detected in this study, in a
previous study we found that NF-B was activated in
response to telomerase-inhibitor-induced senescence of
alveolar type II-like A549 cells [42]. Since telomerase has
been shown to locate to mitochondria, where it decreases
ROS production, inhibition of telomerase may have
increased the formation of ROS, and that may in turn
have activated NF-B [43]. Thus, the mechanism of
senescence-associated inflammation may differ according
to the cell types and senescence inducer. Our findings
also suggest that the pathways that regulate the
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senescence-associated inflammation may be distinct from
the pathways that regulate the senescence growth arrest,
because the p38 MAPK inhibitor SB202190 substantially
diminished senescence-associated inflammation (Figures
6A and 8C) but did not inhibit BrdU-induced growth
arrest, p21 expression, or the increased SA b-gal activity
(Figures 6C, 8D and 8E).
The increased pro-inflammatory cytokine secretion by
senescent epithelial cells (Clara cells) may not be the
sole mechanism responsible for the exacerbated airway
inflammation in our murine model of epithelial cell
senescence. Previous studies have shown that CC10, the
major Clara cell secretory protein (CCSP), exerts anti-
inflammatory effects and can attenuate airway inflam-
mation through inactivation of secretory phospholipase
A2 or regulation of macrophage behavior [44,45]. Thus,
the reduced CC-10 levels in the airway fluid resulting
from ineffective restoration of Clara cells due to senes-
cence growth arrest may also contribute to the mechan-
ism of the increased airway inflammation.
Pro-inflammatory cytokine secretion is one of the com-
plex features of the senescence-associated secretory phe-
notype, which include disruption of normal tissue
structure, promotion of endothelial cell invasion, and sti-
mulation of tumor cell growth and invasion [10,37,46].
Why do senescent cells mount a pro-inflammatory cyto-
kine response? Recent evidence suggests at least two
important roles of senescence-associated pro-inflamma-
tory cytokine secretion [10,37,46]. First, pro-inflamma-
tory cytokines such as IL-6 and IL-8 act in an autocrine
feedback loop to reinforce the senescence growth arrest
and thereby reduce the risk of oncogenic transformation
in a cell-autonomous manner [33,46]. Second, the pro-
inflammatory cytokines mobilize innate immune cells,
such as natural killer cells, that clear senescent cells
[47,48]. These roles suggest that senescence-associated
inflammation is important, especially early after senes-
cence induction, to ensure efficient growth arrest and
eventually to stimulate the immune system to clear
senescent cells [10]. However, senescent cells accumulate
in the tissues with age and in the affected tissues of
patients with age-related diseases such as atherosclerosis
and COPD, probably because either immune clearance is
less efficient and/or the rate at which senescent cells are
produced outpaces the rate of clearance [2,6,9,10]. Con-
sequently, the deleterious effects of cellular senescence, i.
e., impaired tissue restoration and chronic inflammation,
may become apparent with time and contribute to the
pathogenesis of age-related diseases.
If that is true, does cellular senescence contribute to the
onset and progression of COPD? Our findings show accel-
erated senescence of Clara cells in the airways of COPD
patients, and they extend the findings in previous studies,
including our own previous study, demonstrating that
various types of cells, including alveolar type II cells,
endothelial cells, fibroblasts, and peripheral blood lympho-
cytes, senesced more rapidly in COPD patients than in
control subjects [2-5]. In the present study we also
demonstrated an increase in the phosphorylated form of
p38 MAPK in the Clara cells of COPD patients, corrobor-
ating a previous study showing increased numbers of
phospho-p38 MAPK-positive macrophages and phospho-
p38 MAPK-positive alveolar cells in the lungs of COPD
patients [49]. Importantly, we found that p38 MAPK is
preferentially activated by senescent Clara cells rather than
by presenescent cells, indicating a correlation between p38
MAPK activation and senescence at the cellular level in
vivo. There is evidence that p38 MAPK activation plays a
role in recruiting CD8 T lymphocytes into the lungs of
COPD patients, and a p38 MAPK inhibitor has been
shown to be effective in suppressing inflammation in a
model of smoking-induced COPD in mice [49,50]. In light
of all of this evidence, senescence-associated p38 MAPK
activation in Clara cells appears to contribute to the onset
and progression of airway inflammation in COPD.
Conclusions
The results of our study provide evidence that senes-
cence of airway epithelial cells impairs repair processes
and stimulates p38 MAPK-dependent inflammation in
response to airway injury (Figure 10). Our findings are
Figure 10 Pathways by which BrdU impairs epithelial repair
and induces persistent inflammation in the chronic NA injury
model. BrdU induces genotoxic stress, which activates the DNA
damage response, thereby promoting premature senescence, which
results in the growth arrest of epithelial cells. Genotoxic stress
caused by BrdU also activates p38-MAPK pathways that trigger the
production of pro-inflammatory cytokines/chemokines, which
exacerbate inflammation. Which is necessary for p38-MAPK
activation, the DNA damage response or cell cycle arrest (p21, etc.),
has not been determined (broken arrows). Recent evidence indicates
that pro-inflammatory cytokines (e.g., IL-6, IL-8) at least in part
reinforce cell cycle arrest via the DNA damage response pathway
[32,33], suggesting a positive feedback loop (dashed arrow) in which
inflammation in turn promotes senescence.
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of clinical importance, because COPD is characterized
by impaired repair and excessive inflammation and is
associated with accelerated senescence of lung cells
[9,51]. However, the results of study leave many ques-
tions unanswered. Is a DNA damage response or senes-
cence growth arrest required for BrdU-induced
senescence-associated inflammation to occur (Figure
10)? Do other senescence inducers, such as oxidative
stress and cigarette smoke, also induce senescence-asso-
ciated airway inflammation [21]? How long do senescent
cells survive in the airway epithelium of mice and
humans? Does senescence-associated inflammation
account for the persistent airway inflammation in
COPD patients who quit smoking? All of these ques-
tions need to be answered in the future.
Additional material
Additional file 1: Additional methods. The file contains detailed
methods for epithelial repair assay, senescence-associated b-galactosidase
staining, immunohistochemistry and immunofluorescence, and
immunoblot analysis used in this study.
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